Events Search and Views Navigation

Event Views Navigation

Filters

Changing any of the form inputs will cause the list of events to refresh with the filtered results.

Current

    • Oncolytics Key Opinion Leader Discussion Focusing on Pancreatic and Gastrointestinal Cancers

    Join Oncolytics for a key opinion leader (KOL) webinar to discuss pelareorep in metastatic pancreatic ductal adenocarcinoma (mPDAC) and other…
    TIME: 1:00 PM EDT
    LOCATION: Virtual
    View Details

    Bridging the Treatment Gap: Addressing Borderline Personality Disorder with Novel Therapeutics by Oryzon’s Clinical Advisory Board

    Join Oryzon Genomics for a virtual Key Opinion Leader (KOL) event exploring the significant unmet medical need and the evolving…
    TIME: 12:00 PM EDT
    LOCATION: Virtual
    View Details

    Lipocine Virtual R&D Investor Event to Discuss LPCN 1154 (BRLIZIOTM) as a Treatment for Postpartum Depression (PPD)

    Join Lipocine for a virtual R&D investor event featuring key opinion leader (KOL) Dr. Kristina M. Deligiannidis, MD (Zucker Hillside Hospital,…
    TIME: 11:00 AM EDT
    LOCATION: Virtual
    View Details

    I-Mab Biopharma KOL Webinar to Recap New Clinical Data on Givastomig (Claudin 18.2 x 4-1BB) Being Presented at ESMO GI 2025

    Join I-Mab for a KOL webinar featuring Samuel J. Klempner, MD (Associate Professor of Medicine at Massachusetts General Hospital), who…
    TIME: 2:00 PM EDT
    LOCATION: Virtual
    View Details

    • Everest Medicines: A Conversation on the Latest Results from the Ongoing Phase 1b/2a Clinical Trial of EVER001, a Next-Generation Covalent Reversible BTK Inhibitor for the Treatment of Primary Membranous Nephropathy (pMN)

    *Chinese Translation Webcast If you are having trouble seeing the player, please click here.   Join Everest Medicines for a…
    TIME: 8:00 AM EDT
    LOCATION: Virtual
    View Details

    Everest Medicines: A Conversation on the Latest Results from the Ongoing Phase 1b/2a Clinical Trial of EVER001, a Next-Generation Covalent Reversible BTK Inhibitor for the Treatment of Primary Membranous Nephropathy (pMN)

    Join Everest Medicines for a virtual nephrology-focused key opinion leader (KOL) event. The event will feature: Richard Lafayette, MD – Professor…
    TIME: 8:00 AM EDT
    LOCATION: Virtual
    View Details

    Crinetics Pharmaceuticals: In-Person R&D Day 2025 on CRN09682, TSH and SST3

    This page is for in-person registration only. To access the webcast, please click here.  Please join the Crinetics management team…
    TIME: 9:00 AM EDT
    LOCATION: CURE, 345 Park Ave S.
    New York, NY 10010
    View Details

    Elicio Therapeutics Virtual KOL Event to Discuss AMP-Powered ELI-002 for the Treatment of mKRAS-driven Pancreatic Cancer

    Please join the Elicio Therapeutics management team for a virtual key opinion leader (KOL) event to discuss the significant unmet…
    TIME: 2:00 PM EDT
    LOCATION: Virtual
    View Details

    Forte Biosciences Webcast to Discuss Positive Data in FB102 Celiac Disease Phase 1B Study

    Join Forte Biosciences for a conference call to discuss positive data from a Phase 1b trial in celiac disease for…
    TIME: 8:30 AM EDT
    LOCATION: Virtual
    View Details

    ArriVent Virtual Investor Event on Firmonertinib Path Forward for EGFR PACC Mutant NSCLC

    Join ArriVent for a virtual investor event to discuss the firmonertinib clinical program for the treatment of EGFR PACC mutant…
    TIME: 8:00 AM EDT
    LOCATION: Virtual
    View Details

    Senseonics In-Person and Virtual Analyst Event at ADA 2025: Eversense® 365 Continuous Glucose Monitoring System for People with Diabetes

    Please note the webcast will not begin until 8:30 AM CT. Join Senseonics for an in-person and virtual analyst event…
    TIME: 8:00 AM CDT
    LOCATION: Marriott Marquis Chicago, 2121 S Prairie Ave, Chicago, IL 60616
    View Details

    PDS Biotechnology Virtual KOL Event to Discuss Versamune® HPV for the Treatment of HPV16+ HNSCC and the Evolving Treatment Landscape

    Join PDS Biotechnology for a virtual key opinion leader (KOL) event featuring Kevin Harrington, MBBS, PhD (The Institute of Cancer Research,…
    TIME: 12:00 PM EDT
    LOCATION: Virtual
    View Details

    A New Mechanism of Action in Treating Acne: Update on Positive Phase 3 Denifanstat Trial for the Treatment of Moderate to Severe Acne

    Join Sagimet Biosciences for a virtual key opinion leader (KOL) event featuring Neal Bhatia, MD (Director of Clinical Dermatology at…
    TIME: 2:00 PM EDT
    LOCATION: Virtual
    View Details

    Galectin Therapeutics Virtual KOL Event to Discuss Belapectin Development Program for Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH) Cirrhosis and Portal Hypertension

    Join Galectin Therapeutics for a virtual key opinion leader (KOL) event focused on the unmet need and current treatment landscape…
    TIME: 12:00 PM EDT
    LOCATION: Virtual
    View Details

    R&D Call: Deucrictibant: Beyond HAE-1/2

    Join Pharvaris for a virtual R&D call, titled “Deucrictibant: Beyond HAE Type 1/2". The virtual event will explore the pathophysiology…
    TIME: 8:00 AM EDT
    LOCATION: Virtual
    View Details

    Immix Biopharma Virtual KOL Event to Discuss NXC-201 NEXICART-2 Interim Trial Results Presented at ASCO in relapsed/refractory AL Amyloidosis

    Join Immix Biopharma for a Virtual Key Opinion Leader (KOL) event to discuss interim trial results from the NEXICART-2 Phase…
    TIME: 3:00 PM EDT
    LOCATION: Virtual
    View Details